Hector Keun

Hector Keun

Imperial College London

H-index: 63

Europe-United Kingdom

About Hector Keun

Hector Keun, With an exceptional h-index of 63 and a recent h-index of 37 (since 2020), a distinguished researcher at Imperial College London, specializes in the field of metabolic profiling, toxicology, tumour metabolism, NMR spectroscopy, pattern recognition.

His recent articles reflect a diverse array of research interests and contributions to the field:

Safety and preliminary efficacy of pembrolizumab following trans-arterial chemoembolization for hepatocellular carcinoma: the PETAL phase Ib study.

Abstract B096: Targeting RNA splicing factor RBM39 improves therapy responses in ovarian high-grade serous carcinoma

Corrigendum to" In-utero and childhood chemical exposome in six European mother-child cohorts"[Environ. Int. 121 (Part 1)(2018) 751-763]

Hyperacetylated histone H4 is a source of carbon contributing to lipid synthesis

Blurred lines: Crossing the boundaries between the chemical exposome and the metabolome

A phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer

Childhood exposure to non-persistent endocrine disrupting chemicals and multi-omic profiles: A panel study

Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts

Hector Keun Information

University

Position

Professor of Biochemistry

Citations(all)

14907

Citations(since 2020)

5687

Cited By

11441

hIndex(all)

63

hIndex(since 2020)

37

i10Index(all)

146

i10Index(since 2020)

119

Email

University Profile Page

Google Scholar

Hector Keun Skills & Research Interests

metabolic profiling

toxicology

tumour metabolism

NMR spectroscopy

pattern recognition

Top articles of Hector Keun

Safety and preliminary efficacy of pembrolizumab following trans-arterial chemoembolization for hepatocellular carcinoma: the PETAL phase Ib study.

Clinical Cancer Research

2024/4/5

Abstract B096: Targeting RNA splicing factor RBM39 improves therapy responses in ovarian high-grade serous carcinoma

Cancer Research

2024/3/4

Corrigendum to" In-utero and childhood chemical exposome in six European mother-child cohorts"[Environ. Int. 121 (Part 1)(2018) 751-763]

Environment International

2024/3

Hyperacetylated histone H4 is a source of carbon contributing to lipid synthesis

The EMBO Journal

2024/2/21

Blurred lines: Crossing the boundaries between the chemical exposome and the metabolome

2024/2/1

A phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer

Clinical Cancer Research

2023/4/14

Childhood exposure to non-persistent endocrine disrupting chemicals and multi-omic profiles: A panel study

Environment International

2023/3/1

Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts

BMC medicine

2023/2/28

The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality

2023

Chemical Tools for Profiling the Intracellular ADP-ribosylated Proteome

bioRxiv

2023

Heme oxygenase-1 expressing omental macrophages as a therapeutic target in ovarian high grade serous carcinoma

bioRxiv

2023

RBM39: A druggable metabolic sensor linking RNA splicing, transcriptional regulation, and metabolic reprogramming in cancer

Molecular Cell

2023/12/7

Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma

Cell Reports

2023/10/31

P-179 Altered lipid metabolism in IMiD/CELMoD resistant multiple myeloma confers novel and targetable vulnerabilities

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Metabolomics and the exposome

Frontiers in Public Health

2023/6/28

Associations of four biological age markers with child development: A multi-omic analysis in the European HELIX cohort

Elife

2023/6/6

miR-22-enriched breast cancer cells display repressed glycolytic metabolism, increased glycogen synthesis, and reduced survival in low glucose conditions

Molecular Biology Reports

2023/6

Cobalt-Doped g-C3N4 Nanosheets for One-Pot Synthesis of Imines under Mild Conditions

CLINICAL CANCER RESEARCH

2023/4/15

Multi-omics signatures of the human early life exposome

Nature communications

2022/11/21

See List of Professors in Hector Keun University(Imperial College London)

Co-Authors

academic-engine